Abiopharma

Clinical trial NCT05198674: primary completion date: 2026-11-30 → 2026-03-05.

Clinical trial NCT07285239 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-09-01

Clinical trial NCT05850234 updates: 1. completion date: 2028-11-14 → 2029-01-25 2. primary completion date: 2027-08-31 → 2027-10-01 3. enrollment: 182 → 232 participants

Clinical trial NCT07063342: enrollment: 72 → 236 participants.

Clinical trial NCT07570862 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-27

Clinical trial NCT04862663 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 895 → 893 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07542483 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-24

Clinical trial NCT06939413 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-10-01 → 2026-11-01 3. primary completion date: 2026-10-01 → 2026-11-01

Clinical trial NCT07456033 updates: 1. completion date: 2030-07-08 → 2030-09-23 2. primary completion date: 2030-07-08 → 2030-09-23

Clinical trial NCT05825820 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-31 3. completion date: 2026-10-01 → 2027-02-01 4. primary completion date: 2026-10-01 → 2027-01-01

Clinical trial NCT07686757 updates: 1. status: NOT_YET_RECRUITING → ENROLLING_BY_INVITATION 2. start date: 2026-09-01 → 2026-08-12

Clinical trial NCT07719647 updates: 1. start date: 2026-09-01 → 2027-02-01 2. completion date: 2027-09-01 → 2028-02-01 3. primary completion date: 2027-09-01 → 2028-02-01

Clinical trial NCT06216158: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07712874: start date: 2026-08-19 → 2026-08-20.

Clinical trial NCT07209267 updates: 1. start date: 2026-09-01 → 2026-10-01 2. intervention model: SEQUENTIAL → PARALLEL